1. Pharmacokinetics Calculations
Prof. Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D
Department of Pharmaceutics
KLE University’s College of Pharmacy
BELGAUM , Karnataka, India
Cell No:
KLECOP, Nipani

2. Introduction : Pharmacokinetic Parameters: Elimination rate constant
Biological Half life
Rate constant of absorption
Apparent volume of distributions
Area under the curve
KLECOP, Nipani

3. Example : 1
Time (hrs)
Conc (mcg/ml)
1.0
8.0
2.0
6.3
3.0
4.9
4.0
5.0-
3.2
6.0
2.5
7.0
1.9
The plasma concentration after the 250 mg intravenous bolus dose of an antibiotic is given below. Plot the data and describe the pharmacokinetic model.
KLECOP, Nipani

4. Solution :
Graph
KLECOP, Nipani

5. Elimination rate constant :
Suppose we choose the following two points to determine the slope of the straight line :
x1= 0 hr, y1 = 10.0 mcg/ml, and x2 = 7.0hr, y2 = 2.0 mcg/ml. then
ln y2 – ln y1
ln2.0 – ln 10.0 –
Slope = = =
x2 – x1
7.0 hr – 0 hr
7.0 hr = =
/ hr
7.0 hr
Therefore Ke = - slope = - ( /hr) = /hr
KLECOP, Nipani

6. Biological half-life :
Ke =
0.693
t1/2 ,
therefore
t½ =
0.693 Ke
0.2299/hr
0.693
= 3.01 hr =
KLECOP, Nipani

7. Area under curve : Area from 0 to 7.0 hours –
AUC0-7.0 by trapezoidal rule = mcg.hr/ml
AUC0-7.0 by counting squares = mcg.hr/ml
AUC0-7.0 by Cutting and Weighing = mcg.hr/ml
KLECOP, Nipani

8. Total area under curve :
This is a two step method, first determine AUC0-7.0 , then determine AUC7.0-∞
AUC 7.0- ∞ = Ct Ke =
2.0mcg/ml
0.2299/hr
= 8.7 mcg. hr/ml
Adding this value to AUC 0-7.0, we have
AUC0-infi = AUC AUC7.0-∞
= 34.85mcg.hr/ml + 8.7mcg.hr/ml
= 43.50mcg.hr/ml
AUC0-∞ = C0 Ke =
10mcg / ml
0.2299/ hr
= mcg.hr /ml
KLECOP, Nipani

9. Volume of distribution :
Vd =
Dose Co =
250 mg
10 mcg / ml
10 mg/L
= 25 L
KLECOP, Nipani

10. Description of model :
It shoes that a 250mg dose is administered intravenously. The apparent volume of distribution is 25 L and the rate constant of elimination (Ke) is / hr. since biological half-life is 3.01 hr.
25 LITRES
250 mg
intravenous
injection
/ hr
KLECOP, Nipani

11. Example 2
The plasma concentration versus time data following the administration of a single 250 mg rapid intravenous bolus dose of a drug is represented by the biexponential equation;
C = 1.5e-0.13t e–1.3t.
Draw a schematic of the pharmacokinetic model, assuming concentration is in mcg / ml and time is in hours.
KLECOP, Nipani

12. Solution
From the biexponential equation, the following parameters of the two compartment pharmacokinetic model are deduced : b= 0.13/hr (because the smallest hybrid rate constant always b), and B = 1.5 mcg/ml (because B is y-intercept corresponding to b). therefore a must be equal to 1.3/hr, and A = 12.5mcg/ml.
In order to draw a schematic of the pharmacokinetic model, the following parameters need to be calculated: rate constants K10, K12, K21,, and apparent volumes of distribution Vc, and Vt.
KLECOP, Nipani

13. Rate constants K 21 = Ab + Ba B + A = 1.625 + 1.95 1.5 + 12.5 3.575
14.0
= /hr
K10 = ab
K21 =
(1.3/hr) ( o.13/hr)
0.2554/hr
0.169/hr
=0.6617/hr
K12 = a + b – K21 – K10
K12 = 1.3 /hr /hr – / hr – / hr
K12 = / hr
KLECOP, Nipani

14. Apprent volume of distribution
Vc = D =
14 mcg ml
= L
250 mg
B + A
Vc (K12 + K21)
Vd =
K21
Vd =
( L) ( / hr / hr)
/ hr = L
0.2554
= L
Vt = Vd – Vc = L – L = L
Vt =
(Vc) (K12)
K21 =
( L) ( / hr)
/hr
= L
KLECOP, Nipani

15. Schematic representation :
This schematic shows that the 250 mg dose can was given intravenously. The apparent volume of the central and tissue compartment are L and L, respectively. The first-order rate constant of transfer of the from the central compartment into the tissue compartment is /hr and the first-order rate constant of transfer of drug from the tissue compartment in to the central compartment is / hr. the first-order rate constant of elimination of drug from the central compartment is / hr.
KLECOP, Nipani

16. Schematic of the two compartment model
0.5433/hr L
/hr
250 mg
intravenous
injection L
0.2554/hr
KLECOP, Nipani

17. Concentration (mcg/ml)
Example -3
The following data were obtained when a 500 mg dose of an antibiotic was given orally. Calculate the pharmacokinetic parameters, assuming 100% of the administered dose was absorbed.
TIME (Hr)
Concentration (mcg/ml) 1
26.501 2
36.091 3
37.512 4
36.055 5
32.924 6
29.413 8
22.784 16
7.571 18
5.734 20
4.343
KLECOP, Nipani

18. Graph
KLECOP, Nipani

19. Solution: Elimination rate constant:
The rate constant of elimination is calculated from the terminal linear portion of plasma profile.
To determine it, we need to calculate slope of the straight line having y-intercept = B. if natural log are used the rate constant of elimination (b) = negative slope of this straight line.
Therefore
b = - slope
ln ln 4.343
0.2778
= -
= -
= / hr
( ) hr
2 hr
KLECOP, Nipani

20. Biological half life:
The biological half life (t1/2) is determined using the equation
t1/2 = 0.693/b
0.693
0.139/hr
= 4.98 hr =
KLECOP, Nipani

21. The Y-intercept, B
The Y-intercept of this straight line is B and is determined using the first order equation
ln Ct = ln B – bt
Which upon rearrangement gives
ln B = ln Ct + bt
= ln (0.139/hr)(20hr) = =
B = Inverse ln
= 70.0 mcg/ml
KLECOP, Nipani

22. Feathering the curve :
To obtain the straight line which represents absorption phase, the technique of feathering or the method of residuals is used. for example, to feather the first plasma conc. point at 1 hr, the plasma conc. at 1 hr on the straight line having the y intercept = B is subtracted from the plasma conc. data provided in the data.
ln Ct = ln B - bt
ln Ct = ln 70 – (0.139) (1)
= – 0.139 =
Ct = inverse ln = mcg/ml
KLECOP, Nipani

23. Graph
KLECOP, Nipani

24. therefore the residual concentration at 1hr is, 1 hr = 60.916 – 26.501
The residual conc. at 1 hr is obtained by subtracting from this concentration at 1 hr provided in the data.
therefore the residual concentration at 1hr is,
1 hr = –
= mcg/ml
KLECOP, Nipani

25. Rate constant of absorption
The rate constant of absorption is obtained from the slope of the straight line which represent absorption as follows;
ln 70 – ln 0.1
Ka = a = - slope = -
0 hr – 9.22 hr
6.5511
= - hr
= / hr
KLECOP, Nipani

26. Apparent volume of distribution
Since 100% of the administstered dose was absorbed, F = 1. substittuting the values of B= 70mcg/ml, D= 50mg, a = Ka = 0.71/hr, b Ke = 0.139/hr,
B =
(F)(D)(a)
(Vd)(a-b)
(1)(500mg)(0.71/hr)
70 mcg/ml=
(Vd)(0.71/hr – /hr)
(Vd) = mg
70mcg / ml
= L
KLECOP, Nipani

27. Area under the curve 70 mcg/ml B A 70 mcg/ml AUC = - = - b a 0.139/hr
AUC = mcg – hr/ml – mcg – hr /ml
= mcg – hr/ml
KLECOP, Nipani

28. Description of the model
Schematic shows that a 500 mg of the dose of the drug was administered by an extravascular route. The first-order rate constant of absorption is 0.71/hr and the first order rate constant elimination is 0.139/hr. the apparent volume of the central compartment is 8.88 L.
8.88 LITRS
500 mg
0.71 /hr
0.139 / hr
KLECOP, Nipani

29. Concentration (mcg/ml)
Example -3.1
From the data given Calculate the time when administered drug dose reaches its maximum concentration in the plasma.
TIME (Hr)
Concentration (mcg/ml) 1
26.501 2
36.091 3
37.512 4
36.055 5
32.924 6
29.413 8
22.784 16
7.571 18
5.734 20
4.343
KLECOP, Nipani

30. From the pharmacokinetic parameters found, the first-order rate constant of absorption, Ka = 0.71/hr and the first order rate constant elimination, Ke = 0.139/hr.
t max =
ln Ka – ln Ke
Ka – Ke
ln 0.71 /hr – ln /hr
0.71 /hr – /hr
– – ( )
0.571 /hr
1.6308
/hr =
= hr
KLECOP, Nipani

31. Concentration (mcg/ml)
Example -3.2
From the data given Calculate the maximum concentration of the drug in plasma attained after the administration of the dose.
TIME (Hr)
Concentration (mcg/ml) 1
26.501 2
36.091 3
37.512 4
36.055 5
32.924 6
29.413 8
22.784 16
7.571 18
5.734 20
4.343
KLECOP, Nipani

32. B = 70 mcg /ml, Ka = 0. 71 /hr, Ke = 0. 139 /hr, and tmax = t’ = 2
B = 70 mcg /ml, Ka = 0.71 /hr, Ke = /hr, and tmax = t’ = hr
C max =
B (e-bt’ – e-at’)
C max =
(70 mcg/ml) (e-(0.139/hr))(2.856 hr) – e-(0.71/hr)(2.856hr))
C max =
(70 mcg/ml) (0.623 – )
C max =
(70 mcg/ml) (0.5407)
= mcg ml
KLECOP, Nipani

33. Concentration (mcg/ml)
Example -4
The following data were obtained when a 500 mg dose of an antibiotic was given orally calculate the pharmacokinetic parameters, assuming 100% of the administered dose was absorbed.
TIME (Hr)
Concentration (mcg/ml) 2
3.915 4
8.005 6
7.321 8
5.803 10
4.403 16
1.814 18
1.344 20
0.996 24
0.546 28
0.300
KLECOP, Nipani

34. graph
KLECOP, Nipani

35. Elimination rate constant:
The rate constant of elimination (b) is calculated using the terminal two points of the plasma profile as follows;
Therefore
b = - slope
ln mcg/ml - ln mcg/ml
= -
( ) hr
0.5988
= -
= 0.15/ hr
4 hr
KLECOP, Nipani

36. The y-intercept, b, of this straight line is determined using the first-order rate equation :
B = Ct e bt = (0.3 mcg/ml) e(0.15/hr)(28hr)
B = (0.3 mcg/ml) ( )
B = 20 mcg/ml
KLECOP, Nipani

37. To obtained the straight line which represents absorption phase, the technique of feathering is used. The plasma profile is feathered with respect to the straight line having y-intercept = B. To feather the first concentration point, the concentration at 2 hr on the straight line having y- intercept = B is subtracted from the data concentration at 2 hr.
C = Be-bt = (20 mcg/ml)e-(1.5/hr)(2hr)
C = (20 mcg/ml) (0.7408)
= mcg/ml
Therefore, residual concentration at 2 hr is :
mcg/ml – mcg/ml = mcg/ml
KLECOP, Nipani

38. Biological half life:
The biological half life (t1/2) is determined using the equation
t1/2 = 0.693/b
0.693
0.15/hr
= 4.62hr =
KLECOP, Nipani

39. Rate constant of absorption
The rate constant of absorption is obtained from the slope of the straight line having the y-intercept = A. It is calculated as follows;
ln 40 mcg/ml – ln mcg/ml
Ka = a = - slope = -
0 hr – 8 hr
5.198 =
8hr
= / hr
KLECOP, Nipani

40. Lag-Time
Since the value of the y-intercept A is not equal to the value of the y-intercept B, the dosage from exhibits lag-time. The lag-time (L) is determined using equation
ln A – ln B
L =
a – b
ln 40 mcg/ml – ln 0.20 mcg/ml =
0.65 – 0.15
0.693 =
0.5 / hr
= hr
KLECOP, Nipani

41. The equation for calculating the time of maximum concntration of drug in plasma in presence of lag-time, tmax (L), is
ln A – ln B + ln a – ln b
t max =
a - b
ln 40 – ln 20 + ln 0.65 – ln 0.15
t max =
0.65 /hr – /hr
1.4663
t max =
= hr
0.5 /hr
KLECOP, Nipani

42. (20 mcg/ml) (e-(0.15/hr))(4.319 hr) – e-(0.65 /hr)(4.319 hr))
C max (L) =
Be-bt” – Ae-at”)
C max (L) =
(20 mcg/ml) (e-(0.15/hr))(4.319 hr) – e-(0.65 /hr)(4.319 hr))
C max (L) =
(20 mcg/ml) (0.5253) – (40 mcg /ml) (0.0604)
C max (L) =
mcg/ml – mcg /ml
C max (L)
= mcg /ml
KLECOP, Nipani

43. Pharmacokinetics and Pharmacodynamics Parameters
KLECOP, Nipani

44. Measurement of bioavailability
Pharmacokinetic methods ( indirect )
1. Blood analysis
2. Urinary excretion data
Pharmacodynamic methods ( direct )
1. Acute pharmacological response
2. Therapeutic response
18/11/2010
KLECOP, Nipani

45. Blood analysis
Plasma level time studies or The plasma concentration – time curve or blood level curve.
A direct relationship exists concentration of drug at the site of action & concentration of drug in the plasma.
Serial blood samples are taken after drug administration & analyzed for drug concentration.
A typical blood level curve obtained after oral administration of drug.
18/11/2010
KLECOP, Nipani

46. 18/11/2010
KLECOP, Nipani

47. Parameters determined
Pharmacokinetic parameters
Peak Plasma Concentration (Cmax)
Time of Peak concentration (tmax).
Area Under Curve (AUC)
Minimum Effective Concentration (MEC) / Minimum Inhibitory Concentration (MIC).
Maximum Safe Concentration (MSC) / Maximum Safe Dose (MSD).
Duration of action
Onset of action.
Intensity of action.
Pharmacodynamics parameters
18/11/2010
KLECOP, Nipani

48. Parameters determined
AUC or Extent of absorption can be measured by 3 methods…
1.Planimeter
Instrument for mechanically measuring the area
2. Cut & weigh method
AUC is cut & weighed on analytical balance. The weight obtained is converted to proper unit by dividing it by the wt of a unit area of same paper.
3. Trapezoidal method
18/11/2010
KLECOP, Nipani

49. Parameters determined
3. Trapezoidal method
AUC = ½ ( C1 + C2) (t2 – t1) + ½ (C2 + C3) (t3 – t2) +…….
½ (C n-1 + C n ) (tn – tn-1 )
C = Concentration
t = time
subscript= sample number
AUC = Area Under Curve
18/11/2010
KLECOP, Nipani

50. Parameters determined
Relative bioavailability
F rel = ( AUC) drug . (Dose) standard
(AUC) standard .(Dose) drug
Absolute bioavailability
Fab = (AUC)drug . (Dose) IV
(AUC)IV . (Dose) drug
18/11/2010
KLECOP, Nipani

51. Parameters determined
From the following blood data obtained after the oral administration of 50mg of drug A. calculate the AUC?
Time in hr
Plasma drug con in mcg/ml 1
5.5 2
9.2 3
14.9 4
10.3 5
7.3 6
2.2
AUC = ½ ( ) (2-1) + ½ ( ) (3-2) + ½ ( ) (4-3) ½ ( )(5-4) + ½ ( ) (6-5)
AUC = mcg/ml hr
AUC = ½ ( ) (2-1) + ½ ( ) (3-2) + ½ ( ) (4-3) ½ (1AUC = ½ ( ) (2-1) + ½ ( ) (3-2) + ½ ( ) (4-3) ½ ( )(5-4) + ½ ( ) (6-5)
AUC = mcg/ml hr
18/11/2010
KLECOP, Nipani

52. Parameters determined
The AUC of a new sustained release diclofenac sodium developed in the lab after giving in a dose of 100mg was found to be mcg/ml hr.The AUC of the standard marketed sustained release tablets of the same at the same dose was found to be mcg/ml hr. what is the the relative bioavailability of he same drug.
F rel = X 100
X 100
= or 95.77%
18/11/2010
KLECOP, Nipani

53. Parameters determined
The AUC of salbutamol sulphate from a 10 mg IV dose was found to be 94.6mcg/ml hr.when the same dose was given orally, the AUC was found to be 60.5 mcg/ml hr. What is the absolute bioavailability of the drug?
Fabs = X 10
94.6 X 10
Fabs = or 63.95
18/11/2010
KLECOP, Nipani

54. Urinary excretion data
The method of determination bioavailability provided that the active ingredient is excreted unchanged in the significant quantity of urine.
The cumulative amount of active drug excreted in urine is directly proportional to extent of systemic drug absorption.
The rate of drug excretion is directly proportional to rate of systemic drug absorption.
18/11/2010
KLECOP, Nipani

55. Advantages
Useful when there is lack of sufficiently sensitive analytical techniques to measure concentration of drug in plasma.
Noninvasive method therefore better subject compliance.
Convenience of collecting urine samples in comparison to drawing of blood periodically.
If any case the urine drug concentration is low, assaying of larger sample volume is relatively more.
Direct measurement of bioavailability, both absolute & relative is possible without the necessity of fitting the data to the mathematical model.
18/11/2010
KLECOP, Nipani

56. Advantages
18/11/2010
KLECOP, Nipani

57. Advantages Bioavailability is determined by…. F = ( U ) oral . D IV
(U ) IV . D oral
U = Cumulative amt of unchanged drug excreted in
urine
D IV = IV dose
D oral = oral dose
F = absolute bioavailability
18/11/2010
KLECOP, Nipani

58. Advantages
When drug A was administered IV to a group of volunteers, 80% of the 500mg dose was recovered unchanged in the urine. When the same drug was administered to the same volunteers orally.280 mg was recovered unchanged in urine. What is the absolute bioavailability of Drug A following oral administration.
Absolute bioavailability = (cumulative amt.of drug excreted)sample
(cumulative amt.of drug excreted)IV =
400
= 0.7 or 70%
18/11/2010
KLECOP, Nipani

59. Acute pharmacological response
Bioavailability can be determined from the acute pharmacologic effect – time curve as well as from dose response graph.
DISADVANTAGE is that pharmacological response tends to more variable & accurate correlation between the measured response & drug available from the formulation is difficult.
18/11/2010
KLECOP, Nipani

60. Therapeutic response
This method is based on the observing the clinical response to a drug formulation given to a patients suffering from disease for which it is intended to be used.
Ex …for anti inflammatory drugs, the reduction in the inflammation is determined.
The major DRAWBACK is …quantification of observed response is too improper to allow for reasonable assessment of relative bioavailability between two dosage forms of a same drug.
18/11/2010
KLECOP, Nipani

61. Rate of Absorption
AUC/dose gives an average extent of bioavailability.
The rate of absorption is usually also important
for the onset of drug action.
The time of peak plasma concentration is used
often as a measure of the rate of drug absorption.
The peak plasma concentration is also an
important parameter - for keeping the drug
concentration within the therapeutic window.
Absorption can be characterized by evaluating the absorption rate constant Ka from the plasma concentration –time data.
18/11/2010
KLECOP, Nipani

62. The method of ‘Residuals’
Also called as Feathering or peeling or stripping.
ASSUMPTIONS
Absorption & elimination process follows 1st order kinetics.
Absorption from the dosage form is complete.
Ka is at least five times larger than Ke
Kinetic model is
AG AB AE Ka Kc
18/11/2010
KLECOP, Nipani

63. The method of ‘Residuals’
18/11/2010
KLECOP, Nipani

64. The method of ‘Residuals’
This technique is used to resolve a multiexponential curve into its individual components.
For a drug that follows one compartment kinetics & administered e.v, the concentration of drug in plasma is expressed by…
C = Ka F X [ e –kEt – e –Kat ]
Vd ( Ka –KE )
If Ka F X0 / Vd ( Ka – kE ) = A, a hybrid constant then,
C = A e –kEt -A e –Kat 1 2
18/11/2010
KLECOP, Nipani

65. The method of ‘Residuals’
During the elimination phase, when the absorption is almost over, Ka > > KE & the value of second exponential e –Kat approaches zero whereas the 1st exponential e –kEt retains some finite value….at this time the equation is
C = A e –kEt in log form
log C = log A – KEt/ 2.303
Where C is the back extrapolated plasma concentration value.
A plot of log C versus t yields a biexponential curve with a terminal linear phase having slope KE/ 3 4
18/11/2010
KLECOP, Nipani

66. The method of ‘Residuals’
Back extrapolation of this straight line to zero yields y-intercept equal to log A.
Subtraction of true plasma concentration values that is equation 2 from the extrapolated plasma concentration values that is equation 3 yields a series of residual concentration values Cr
( C - C ) = Cr = A e –Kat ,
in log form the equation is :
log Cr = log A - Kat/ 2.303
18/11/2010
KLECOP, Nipani

67. The method of ‘Residuals’
A plot of logCr versus t yields a straight line with slope –Ka / & y intercept log A.
Absorption half life can be computed from Ka using the relation 0.693/Ka …thus the method of residual enables resolution of the biexponential plasma level time curve into its exponential components.
The technique works best when the difference between Ka & KE is large ( Ka >= 3)
18/11/2010
KLECOP, Nipani

68. Wagner Nelson Method ASSUMPTIONS
The body behaves as a single homogenous compartment.
Drug elimination obeys 1st order kinetics.
DISADVANTAGES
The absorption & elimination processes can be quite similar & still accurate determination of Ka can not be made.
The absorption process doesn’t have to be 1st order.
The kinetics of absorption may be zero order, mixed order, mixed zero order & 1st order or even more complex.
This method involves determination of Ka from percent absorbed –time plot & does not require the assumption of zero .
18/11/2010
KLECOP, Nipani

69. Wagner Nelson Method
The amount of drug in the body X & the amt of drug eliminated in the body XE thus :
XA = X + XE
If the amt of drug in the body is X = V.dC…the amt of drug eliminated at any time t can be calculated as ..
XE = KE Vd ( AUC)to
Substitution of values of X & XE in above equation…
XA = Vd C + KE Vd ( AUC)to
from this equation we can get the value for drug absorbed in to the systemic circulation from time zero to
18/11/2010
KLECOP, Nipani

70. Wagner Nelson Method
18/11/2010
KLECOP, Nipani

71. E-mail: bknanjwade@yahoo.co.in
Thank you…..
Cell No:
KLECOP, Nipani